A 1.6-million-birth analysis finds that adoption of a 2016 trial's antibiotic protocol climbed sharply in US hospitals, with a drop in infection rates.
|Articles|December 11, 2007
Orphan drug under study to be available to more patients
Gentium expands access to defibrotide under compassionate use basis
Advertisement
Gentium S.p.A has announced that it is expanding access to its investigational drug defibrotide for patients to treat severe veno-occlusive disease (VOD). The Villa Guardia, Italy, firm is taking this step because it has received "large numbers of requests" for the drug on a compassionate use basis. Gentium added that the expanded access will not affect the Phase III trial of the drug, since only patients who are not eligible to, or cannot, participate in the study can take advantage of the expanded access program. Defibrotide is an orphan drug that has been granted fast-track designation to treat severe VOD in stem cell transplant patients.
Advertisement
Related to this article
New findings suggest semaglutide's benefits may extend well beyond diabetes and weight loss and into airway disease and mood disorders.
First approved for adults in 2022, the therapy is now cleared for adults and pediatric patients weighing 66 lbs or more with symptomatic obstructive hypertrophic cardiomyopathy.
With the inherent value medications provide in the greater health care system, Jennifer Hammons, PharmD, DrPH, argues that rural pharmacies deserve the proper recognition.
A claims analysis of 2031 patients aged 10 to 17 years found that nutrition counseling was infrequent and often began months after treatment started.
Community pharmacists offer accessible care, improve medication adherence, and build trust through education, vaccination support, and local health leadership.
Researchers compared vaccine coadministration with single-dose, sequential vaccination for the RSVPreF3 OA vaccine formulation in adults.
A study of women aged 50 to 69 years found that thrombotic risk varied by route of administration, estradiol dose, and duration of use.
Advertisement
Advertisement